Measuring Transparency to Improve Good Governance in the Public Pharmaceutical Sector

Syrian Arab Republic

March 2010
More details
  • Publisher
    World Health Organization
  • Published
    3rd March 2010
  • ISBN 9789290216520
  • Language English
  • Pages 98 pp.
  • Size 9.5" x 6.75"
  • Images b/w graphs & charts

In recent years, countries of the WHO Eastern Mediterranean Region have made significant achievements in the provision of health services. In the pharmaceutical field, countries have been striving to improve the structures and regulations pertaining to medicines and have progressed in many ways. However, there are still important challenges. The goal of the WHO Good Governance for Medicines program is to improve the situation of medicine regulation and supply. National transparency assessment is the beginning of a process aimed at bringing about desirable and sustainable changes in the governance of the pharmaceutical sector. These reports present the findings of the first phase of the national Good Governance for Medicines program in Jordan, Lebanon, Morocco, Pakistan and Syrian Arab Republic.